Glofitamab in Combination with Rituximab Plus Ifosfamide, Carboplatin, and Etoposide Shows Favorable Efficacy and Manageable Safety in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Eligible for Stem Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: Results from a Phase Ib Study
Catherine Diefenbach,Paolo F. Caimi,Nakhle S. Saba,Fernando Vargas Madueno,Mehdi Hamadani,Luis Fayad,Peter A. Riedell,Andrew Gillis-Smith,Stephen J. Simko,Victor M. Orellana‐Noia,Maria Filippou-Frye,Amy V. Kapp,James Relf,Linda Lundberg,Lauren Pinter‐Brown
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
cdercder
123
GingerF
OK
Nole
渡人舟
小鱼儿
张欢馨
东方元语
Sledge
刻苦的长颈鹿
Criminology34
vampv
研研
ming2026
woshi123
heekkll
失眠翠芙
Yangyang
皖公网安备34019202002308
